Nucleotide coenzyme
NAD+
A peptide-adjacent topic included because it appears in the same communities and vendor catalogs. NAD+ is a coenzyme, not a peptide.
Why it is discussed
Cellular-energy, aging, and intravenous-wellness claims
NAD+ is discussed in energy-metabolism, aging, recovery, and intravenous-wellness conversations. It is a dinucleotide coenzyme—not a peptide. Limited human studies of particular preparations or settings do not establish broad benefits, product equivalence, an authorized wellness indication, or the quality of an online vial.
What it is
A metabolic coenzyme—not a peptide.
NAD+ stands for nicotinamide adenine dinucleotide. It is a dinucleotide coenzyme: a small molecule that helps enzymes carry out reactions, rather than a chain of amino acids. The plus sign identifies its oxidized form; NADH is the corresponding reduced form. It is included here because it appears in many of the same community discussions.
How it works
Electron transfer and other enzyme reactions inside cells.
NAD+ accepts electrons during metabolic reactions and becomes NADH. Recycling between these forms supports the processing of nutrients and cellular energy metabolism. NAD+ is not ATP, and adding it externally does not automatically increase useful energy in a particular tissue.
NAD+ also participates in reactions that consume the molecule. A small human infusion study measured changes in NAD+ and its breakdown products in blood and urine. Those measurements describe metabolism; they do not show that intact infused NAD+ reached every desired cellular compartment or produced an anti-aging benefit.
The body's need for this coenzyme does not establish a wellness indication, a safe infusion, or equivalence to NAD+ precursors, which are different molecules.
Scientific / evidence sources
Evidence at a glance
What is established—and what is not.
Related-compound context with limited human intervention evidence
NAD+ is an essential endogenous coenzyme, and limited human studies have examined particular intravenous preparations and metabolic endpoints.
Those studies do not establish broad anti-aging or wellness benefits, product equivalence, an authorized injectable indication, or the quality and sterility of products sold online.
Regulatory status
Canada and the United States are checked separately.
NAD+ is not a peptide. Health Canada lists unauthorized injectable NAD+ among products of concern, and no authorized NAD+ injectable drug was identified in the current Drug Product Database review.
No FDA-approved NAD+ injectable product was identified. FDA has warned that food-grade NAD+ is unsuitable for sterile compounding and has received adverse-event reports following injectable NAD+ products.
Regulatory status describes product authorization and relevant regulatory context. It is not a complete legal opinion about possession, importation, prescribing, sale, or professional practice.
If you are reviewing a product report
The molecule profile and the testing report answer different questions.
This page summarizes evidence and regulatory context. A laboratory report may address identity, purity, or quantity for one submitted sample; it does not transfer clinical evidence or product authorization.